GRg3 ultimately achieves the therapeutic effect of radiotherapy sensitization by inhibiting the proliferation of lung cancer cells, accelerating the process of apoptosis, increasing the proportion of cells in the G2/M phase, preventing the formation of cell colonies, and decreasing the expression levels of PI3K, p-AKT, and PDK1 in cells (23). The gene discussed is TLE3; the disease is lung cancer.